Справка
x
Поиск
Закладки
Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Опухоли слюнных желез у детей
Список литературы
Поставить закладку
Mozaffari H.R. et al. Malignant salivary gland tumors and Epstein-Barr virus (EBV) infection: A systematic review and meta-analysis // Asian Pacific Journal of Cancer Prevention. Asian Pacific Organization for Cancer Prevention, 2017. Vol. 18, № 5. P. 1201–1206.
Whatley W.S., Thompson J.W., Rao B. Salivary gland tumors in survivors of childhood cancer // Otolaryngology - Head and Neck Surgery. Mosby Inc., 2006. Vol. 134, № 3. P. 385–388.
Ethunandan M. et al. Parotid neoplasms in children: experience of diagnosis and management in a district general hospital // Int J Oral Maxillofac Surg. Churchill Livingstone, 2003. Vol. 32, № 4. P. 373–377.
Fu H. et al. Pleomorphic adenoma of the salivary glands in children and adolescents // J Pediatr Surg. W.B. Saunders, 2012. Vol. 47, № 4. P. 715–719.
De Ribeiro K.C.B. et al. Epithelial salivary glands neoplasms in children and adolescents: a forty-four-year experience // Med Pediatr Oncol. Med Pediatr Oncol, 2002. Vol. 39, № 6. P. 594–600.
Yoshida E.J. et al. Salivary gland malignancies in children // Int J Pediatr Otorhinolaryngol. Elsevier, 2014. Vol. 78, № 2. P. 174–178.
Zamani M. et al. Survival and characteristics of pediatric salivary gland cancer: A systematic review and meta-analysis // Pediatric Blood and Cancer. John Wiley and Sons Inc., 2019. Vol. 66, № 3.
Laikui L. et al. Epithelial salivary gland tumors of children and adolescents in west China population: a clinicopathologic study of 79 cases // Journal of Oral Pathology & Medicine. John Wiley & Sons, Ltd, 2008. Vol. 37, № 4. P. 201–205.
Liu B. et al. Pediatric parotid tumors: Clinical review of 24 cases in a Chinese population // Int J Pediatr Otorhinolaryngol. 2012. Vol. 76, № 7. P. 1007–1011.
Skálová A., Hyrcza M.D., Leivo I. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands // Head Neck Pathol. Springer, 2022. Vol. 16, № 1. P. 40–53.
Ashraf A. et al. Diagnostic reliability of FNAC for salivary gland swellings: A comparative study // Diagn Cytopathol. John Wiley & Sons, Ltd, 2010. Vol. 38, № 7. P. 499–504.
Carrillo J.F. et al. Diagnostic accuracy of fine needle aspiration biopsy in preoperative diagnosis of patients with parotid gland masses // J Surg Oncol. John Wiley & Sons, Ltd, 2009. Vol. 100, № 2. P. 133–138.
Eytan D.F. et al. Utility of preoperative fine needle aspiration in parotid lesions // Laryngoscope. John Wiley & Sons, Ltd, 2018. Vol. 128, № 2. P. 398–402.
Fakhry N. et al. Fine needle aspiration cytology and frozen section in the diagnosis of malignant parotid tumours // Int J Oral Maxillofac Surg. Churchill Livingstone, 2014. Vol. 43, № 7. P. 802–805.
Gudmundsson J.K., Ajan A., Abtahi J. The accuracy of fine-needle aspiration cytology for diagnosis of parotid gland masses: a clinicopathological study of 114 patients // J Appl Oral Sci. J Appl Oral Sci, 2016. Vol. 24, № 6. P. 561–567.
Altin F. et al. Is fine needle aspiration biopsy reliable in the diagnosis of parotid tumors? Comparison of preoperative and postoperative results and the factors affecting accuracy // Braz J Otorhinolaryngol. Elsevier, 2019. Vol. 85, № 3. P. 275–281.
Rzepakowska A. et al. The differential diagnosis of parotid gland tumors with high-resolution ultrasound in otolaryngological practice // European Archives of Oto-Rhino-Laryngology. Springer Verlag, 2017. Vol. 274, № 8. P. 3231–3240.
Inohara H. et al. The role of fine-needle aspiration cytology and magnetic resonance imaging in the management of parotid mass lesions // Acta Otolaryngol. 2008. Vol. 128, № 10. P. 1152–1158.
Liu Y. et al. Accuracy of diagnosis of salivary gland tumors with the use of ultrasonography, computed tomography, and magnetic resonance imaging: a meta-analysis // Oral Surg Oral Med Oral Pathol Oral Radiol. Mosby, 2015. Vol. 119, № 2. P. 238-245.e2.
Alibek S. et al. The Value of Dynamic MRI Studies in Parotid Tumors // Acad Radiol. Elsevier, 2007. Vol. 14, № 6. P. 701–710.
Zheng Y. et al. Differentiation between benign and malignant palatal tumors using conventional MRI: a retrospective analysis of 130 cases // Oral Surg Oral Med Oral Pathol Oral Radiol. Mosby Inc., 2018. Vol. 125, № 4. P. 343–350.
Geiger J.L. et al. Management of Salivary Gland Malignancy: ASCO Guideline // J Clin Oncol. 2021. Vol. 39. 1909–1941 p.
Roh J.-L. et al. Clinical Utility of 18 F-FDG PET for Patients with Salivary Gland Malignancies // J Nucl Med. 2007. Vol. 48. 240–246 p.
Cermik T.F. et al. FDG PET in detecting primary and recurrent malignant salivary gland tumors // Clin Nucl Med. 2007. Vol. 32, № 4. P. 286–291.
Kim M.J. et al. Utility of 18F-FDG PET/CT for detecting neck metastasis in patients with salivary gland carcinomas: Preoperative planning for necessity and extent of neck dissection // Ann Surg Oncol. Springer, 2013. Vol. 20, № 3. P. 899–905.
Schmidt R.L., Hall B.J., Layfield L.J. A systematic review and meta-analysis of the diagnostic accuracy of ultrasound-guided core needle biopsy for salivary gland lesions // American Journal of Clinical Pathology. 2011. Vol. 136, № 4. P. 516–526.
Kim H.J., Kim J.S. Ultrasound-guided core needle biopsy in salivary glands: A meta-analysis // Laryngoscope. John Wiley & Sons, Ltd, 2018. Vol. 128, № 1. P. 118–125.
Romano E.B. et al. Fine-needle aspiration with selective use of core needle biopsy of major salivary gland tumors // Laryngoscope. John Wiley & Sons, Ltd, 2017. Vol. 127, № 11. P. 2522–2527.
Rossi E.D. et al. The Milan System for Reporting Salivary Gland Cytopathology: Analysis and suggestions of initial survey // Cancer Cytopathol. John Wiley & Sons, Ltd, 2017. Vol. 125, № 10. P. 757–766.
Farahani S.J., Baloch Z. Retrospective assessment of the effectiveness of the Milan system for reporting salivary gland cytology: A systematic review and meta-analysis of published literature // Diagn Cytopathol. John Wiley & Sons, Ltd, 2019. Vol. 47, № 2. P. 67–87.
Park W. et al. Risk of high-grade malignancy in parotid gland tumors as classified by the Milan System for Reporting Salivary Gland Cytopathology // J Oral Pathol Med. J Oral Pathol Med, 2019. Vol. 48, № 3. P. 222–231.
Johnson D.N. et al. Cytologic grading of primary malignant salivary gland tumors: A blinded review by an international panel // Cancer Cytopathol. John Wiley and Sons Inc., 2020. Vol. 128, № 6. P. 392–402.
Qureshi S.S. et al. Clinical characteristics and treatment outcomes of primary and recurrent malignancy involving the salivary glands in children // Head Neck. John Wiley & Sons, Ltd, 2016. Vol. 38, № 6. P. 852–856.
Zenga J. et al. Close Margins and Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Parotid Gland // JAMA Otolaryngol Head Neck Surg. American Medical Association, 2018. Vol. 144, № 11. P. 1011.
Zenga J. et al. Mucoepidermoid Carcinoma of the Parotid: Very Close Margins and Adjuvant Radiotherapy // ORL. S. Karger AG, 2019. Vol. 81, № 1. P. 55–62.
Stodulski D. et al. Close surgical margin after conservative parotidectomy in early stage low-/intermediate-grade parotid carcinoma: Outcome of watch and wait policy // Oral Oncol. Pergamon, 2017. Vol. 68. P. 1–4.
Ullah A. et al. Mucoepidermoid Carcinoma of the Salivary Gland: Demographics and Comparative Analysis in U.S. Children and Adults with Future Perspective of Management // Cancers (Basel). MDPI, 2023. Vol. 15, № 1.
Grant S.R. et al. Proton versus conventional radiotherapy for pediatric salivary gland tumors: Acute toxicity and dosimetric characteristics // Radiotherapy and Oncology. Elsevier Ireland Ltd, 2015. Vol. 116, № 2. P. 309–315.
Surun A. et al. Salivary gland carcinoma in children and adolescents: The EXPeRT/PARTNER diagnosis and treatment recommendations // Pediatr Blood Cancer. John Wiley and Sons Inc, 2021. Vol. 68, № S4.
Wang X. et al. Management of salivary gland carcinomas-a review. 2017. Vol. 8, № 3. 3946–3956 p.
Ryan J.T. et al. Primacy of surgery in the management of mucoepidermoid carcinoma in children // Head Neck. John Wiley & Sons, Ltd, 2011. Vol. 33, № 12. P. 1769–1773.
Spiro R.H. Salivary neoplasms: Overview of a 35-year experience with 2,807 patients // Head Neck Surg. John Wiley & Sons, Ltd, 1986. Vol. 8, № 3. P. 177–184.
Fushimi C. et al. A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma // Annals of Oncology. Oxford University Press, 2018. Vol. 29, № 4. P. 979–984.
Morse E. et al. Positive surgical margins in parotid malignancies: Institutional variation and survival association // Laryngoscope. John Wiley & Sons, Ltd, 2019. Vol. 129, № 1. P. 129–137.
North L. et al. Intermediate-grade carcinoma of the parotid and the impact of adjuvant radiation // Am J Otolaryngol. W.B. Saunders, 2019. Vol. 40, № 6. P. 102282.
Glas A.S. et al. Surgical treatment of recurrent pleomorphic adenoma of the parotid gland: A clinical analysis of 52 patients // Head Neck. John Wiley & Sons, Ltd, 2001. Vol. 23, № 4. P. 311–316.
Aro K., Leivo I., Mäkitie A. Management of salivary gland malignancies in the pediatric population // Current Opinion in Otolaryngology and Head and Neck Surgery. Lippincott Williams and Wilkins, 2014. Vol. 22, № 2. P. 116–120.
Xiao C.C. et al. Predictors of Nodal Metastasis in Parotid Malignancies // Otolaryngology–Head and Neck Surgery. John Wiley & Sons, Ltd, 2016. Vol. 154, № 1. P. 121–130.
Wang Y.L. et al. Predictive index for lymph node management of major salivary gland cancer // Laryngoscope. John Wiley & Sons, Ltd, 2012. Vol. 122, № 7. P. 1497–1506.
Ali S. et al. Treatment of the neck in carcinoma of the parotid gland // Ann Surg Oncol. Springer New York LLC, 2014. Vol. 21, № 9. P. 3042–3048.
Lim C.M. et al. Is level V neck dissection necessary in primary parotid cancer? // Laryngoscope. John Wiley & Sons, Ltd, 2015. Vol. 125, № 1. P. 118–121.
Dominik T. Schneider et al. Salivary gland carcinomas in children and adolescents: A retrospective analysis of the European Cooperative Study Group for Pediatric Rare Tumours (EXPeRT) // EJC Paediatric Oncology Volume 2, December 2023, 100129
Злокачественные опухоли слюнных желез // Клинические рекомендации Минздрава РФ // Год утверждения (частота пересмотра):2024
E.C. Fortune IV 1, D.J. Indelicato 1, R.Mailhot Vega 1, S. Bradfield 2, J.A. Bradley 1 Outcomes Following Proton Radiotherapy for Pediatric Salivary Gland Tumors
Для продолжения работы требуется
Регистрация
Предыдущая страница
Следующая страница
Оглавление
Список сокращений
Термины и определения
Опухоли слюнных желез у детей
+
Список литературы
Приложение А1. Состав рабочей группы по разработке и пересмотру клинических рекомендаций
Приложение А2. Методология разработки клинических рекомендаций
Приложение А3. Справочные материалы, включая соответствие показаний к применению и противопоказаний, способов применения и доз лекарственных препаратов, инструкции по применению лекарственного препарата
Приложение Б. Алгоритмы действий врача
Приложение В. Информация для пациента
Приложение Г1-ГN. Шкалы оценки, вопросники и другие оценочные инструменты состояния пациента, приведенные в клинических рекомендациях
Данный блок поддерживает скрол*